Abstract. Long non-coding RNAs (lncRNAs) have recently emerged as a major class of regulatory molecules involved in a broad range of biological processes and complex diseases. Our aim was to identify important lncRNAs that might play an important role in contributing to glioblastoma (GBM) pathogenesis by conducting lncRNA and mRNA profile comparison between GBM and normal brain tissue. The differentially expressed lncRNA and mRNA profiles of the tissue between GBM patient and age-matched donor without GBM diseases were analyzed using microarrays. We propose a novel model for the identification of lncRNA-mRNA targeting relationships that combine the potential targets of the differentially expressed lncRNAs with the differentially expressed mRNA abundance data. Bioinformatic analysis of the predicted target genes (gene ontology, pathway and network analysis) was performed for further research. The lncRNA microarray reveals differentially expressed lncRNAs between GBM and normal brain tissues. In the GBM group, 654 lncRNAs were upregulated and 654 were downregulated (fold change ≥4.0 or ≤0.25, P<0.01). We found 104 matched lncRNAmRNA pairs for 91 differentially expressed lncRNAs and 84 differentially expressed genes. Target gene-related pathway analysis showed significant changes in PPAR pathways in the GBM group compared with the normal brain group (P<0.05).
Introduction
Glioblastoma (GBM) is the most common and aggressive type of primary brain tumor in human (1, 2) . In the past two decades, the molecular mechanisms, genetics and pathways to treat GBM have extensively been studied. However, the precise mechanism of GBM is unknown and its median survival rate is very low (3, 4) . The Cancer Genome Atlas (TCGA) generated large-scale multi-dimensional datasets to catalogue cancer alterations. GBM is the first cancer studied by TCGA (5) .
Large-scale analyses of full-length cDNA sequences have detected large numbers of long non-coding RNAs (lncRNAs) in human, mouse and fly. These lncRNAs have been shown to play key roles in imprinting control, cell differentiation, immune responses, human diseases, tumorigenesis and other biological processes (6) . In particular, the regulatory roles of lncRNAs in the expression, activity and localization of protein-coding genes have attracted attention (7) . Although an increasing number of lncRNAs are being characterized, the functions of most lncRNAs are still unknown (8) . Generally, lncRNAs are as poorly conserved as the introns of coding genes and less conserved than the 5'-or 3'-untranslated regions (UTRs) of mRNAs. However, lack of conservation does not necessarily mean lack of function, as demonstrated by the very poorly conserved lncRNA Xist transcript, which plays a critical role in regulation of imprinted and random X inactivation (9). The low-conservation level of lncRNAs suggests they evolve more quickly than protein-coding genes, rendering functional LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis LEI HAN [1] [2] [3] , KAILIANG ZHANG [1] [2] [3] prediction by genomic comparison very difficult. Besides, functional prediction of lncRNAs is also hampered by the lack of collateral information. It has been proposed that the functional properties of lncRNAs are mainly related to their secondary structures (10) . In spite of much effort, the number of lncRNAs with known functions remains scarce, and efficient prediction of lncRNA functions is still a considerable challenge. In the past, although enormous efforts toward generating high-throughput genetic and molecular data have been made, unravelling the mechanisms of GBM remains unresolved via integrating genetic and molecular data. It is increasingly recognized that lncRNAs have emerged as an important component in the regulation of gene expression. In this study, we profiled lncRNAs and mRNAs expression in the tissue of GBM and normal brain by microarray. The differentially expressed lncRNAs were then selected to bioinformatic analyses for target prediction. To improve the accuracy of target prediction, we further combined differentially expressed mRNA with target prediction of differentially expressed lncRNAs. The predicted target genes above are subjected to bioinformatic analyses, including gene ontology analysis, pathway analysis, and network analysis. Analyzing the potential molecular markers and the possible relationship between the differentially expressed protein-coding genes and lncRNAs in GBM will help to give further insight into the pathogenesis of GBM.
Materials and methods
Sample preparation and RNA extraction. One GBM tissue from a 57-year-old female and one normal brain tissue from an agematched female donor without GBM diseases were obtained according to clinical protocols at the clinical medical college of Yangzhou University. The patient had not received prior treatment. As shown in Fig. 1 , imaging and histopathological analysis revealed GBM. Following informed consent at the time of acquisition, the samples were collected, and stored at liquid nitrogen. Tissue samples were homogenized in TRIzol reagent (Invitrogen, CA). The total RNA was isolated according to the manufacturer's protocol (Invitrogen). RNA quantity and quality were measured by NanoDrop ND-1000 and RNA integrity was assessed using standard denaturing agarose gel electrophoresis (11) .
Profiling of lncRNA and mRNA expression in GBM and normal brain samples lncRNA and mRNA microarray. The Human 12x135k long noncoding RNA array was manufactured by Roche NimbleGen. Each array represented all long transcripts, both protein coding mRNAs and lncRNAs in the human genome. More than 23,000 lncRNAs were collected from the authoritative data sources including NCBI RefSeq, UCSC, RNAdb, lncRNAs from literatures and UCRs. Each transcript is represented by 1-5 probes to improve statistical confidence.
RNA labeling and array hybridization. Double-strand cDNA (ds-cDNA) was synthesized from 5 µg of total RNA using an Invitrogen SuperScript ds-cDNA synthesis kit in the presence of 100 pmol oligo dT primers. ds-cDNA was cleaned and labeled in accordance with the NimbleGen Gene Expression Analysis protocol (NimbleGen Systems, Inc., Madison, WI, USA). Microarrays were hybridized at 42˚C for 16 to 20 h with 4 µg of Cy3 labelled ds-cDNA in NimbleGen hybridization buffer/hybridization component A in a hybridization chamber (Hybridization System-NimbleGen Systems, Inc.). Following hybridization, washing was performed using the NimbleGen Wash Buffer kit (NimbleGen Systems, Inc.). After being washed in an ozone-free environment, the slides were scanned using the Axon GenePix 4000B microarray scanner.
Data analysis. Slides were scanned at 5 µm/pixel resolution using an Axon GenePix 4000B scanner (Molecular Devices Corporation) piloted by GenePix Pro 6.0 software (Axon). Scanned images were then imported into NimbleScan software (version 2.5) for grid alignment and expression data analysis. Expression data were normalized through quantile normalization and the Robust Multichip Average (RMA) algorithm included in the NimbleScan software. The Probe level files and mRNA level files were generated after normalization. All mRNA level files were imported into Agilent GeneSpring GX software (version 11.0) for further analysis. Differentially expressed lncRNAs and mRNAs were identified through Fold Change filtering.
lncRNA target prediction Identify the targets of differentially expressed lncRNAs via cisor trans-regulatory effects.
Differentially expressed lncRNAs were selected for target prediction. Two independent algorithms were used. The first algorithm searches for target genes acting in cis. With the help of gene annotations at UCSC (http://genome. ucsc.edu/), lncRNAs and potential target genes were paired and visualized using UCSC genome browser. The genes transcribed within a 10 kbp window upstream or downstream of lncRNAs were considered as cis target genes. The second algorithm is based on mRNA sequence complementarity and RNA duplex energy prediction, assessing the impact of lncRNA binding on complete mRNA molecules. It uses the BLAST software for first round screening. Finally, the RNAplex software was used to choose trans-acting target genes (12) . RNAplex parameters were set as -e -20.
Combine differentially expressed mRNAs with target prediction of differentially expressed lncRNAs. The second step was to integrate the predicted potential lncRNA targets above with the differently expressed mRNAs in the profile (fold change ≥4.0 or ≤0.25).
Functional group analysis. The predicted target genes above were input into the Database for Annotation, Visualization and Integrated Discovery (DAVID, http://david.abcc.ncifcrf.gov/), which leveraged the Gene Ontology (GO) to identify the molecular function represented in the gene profile (13) . In addition, we used the KEGG (Kyoto Encyclopedia of Genes and Genomes) database (http://www.genome.ad.jp/kegg/) and BioCarta (http:// www.biocarta. com) to analyze the roles of these target genes in the pathways (14) .
Discovery of lncRNA-mRNA regulatory network. To show that the lncRNAs directly regulated the expression of targets mRNAs, we superimposed lncRNA target predictions onto the lncRNA-mRNA correlation network. The resulting network was defined as an lncRNA-mRNA regulatory network. A direct connection was placed from an lncRNA to an mRNA using the solid line (trans interaction) or dotted line (cis interaction).
Statistical analysis.
All the results were expressed as mean ± standard deviation. Statistical analysis was done with the Student's t-test for comparison of two groups in microarray, and analysis of variance for multiple comparisons. In both cases, differences with P<0.05 were considered statistically significant. The statistically significance of microarray result was analyzed by fold change and the Student's t-test. False discovery rate (FDR) was calculated to correct the P-value. The threshold value we used to screen differentially expressed lncRNAs and mRNAs is a fold change ≥4.0 or ≤0.25 (P<0.01).
Results
lncRNAs are aberrantly expressed in GBM compared with normal brain. To study the potential biological functions of lncRNAs in GBM, we determined the lncRNA and mRNA expression profile in human GBM through microarray analysis (Fig. 2) . Using the authoritative data sources consisting of more than 23,000 lncRNAs, we firstly assessed the lncRNA expression profiles in the GBM and normal brain tissues. The expression profiles of 1308 lncRNAs determined to be different expression (fold change ≥4.0 or ≤0.25, P<0.01) between GBM and normal brain samples. Among these, 654 lncRNAs were identified to be upregulated more than four-fold in GBM group compared with that in normal brain group, while 654 lncRNAs were downregulated more than four-fold (P<0.01).
Potential targets of the differentially expressed lncRNAs are integrated with differentially expressed mRNAs.
Since lncRNAs regulate the expression of its target genes, the next step is to construct the relationship between the expression profile of the mRNA and predicted target genes of differentially expressed lncRNAs. Procedures for discovering the target genes consisted of two steps. The first step was to predict potential lncRNA targets in the database via target prediction programs. The second step was to integrate the predicted potential lncRNA targets with the different expressed the mRNAs in the profile (fold change ≥4 or ≤0.25, P<0.01). The above methods were PPAR pathway might be regulated by lncRNAs according to bioinformatics analyses. GO analysis showed that the high-enrichment GO targeted by both overexpressed and underexpressed lncRNAs were other metabolic processes ( Fig. 3 and Table I ). The pathway analyses revealed that there were 17 different pathways corresponding to the target genes, one of which was the PPAR signaling pathway in the GBM group compared with the normal brain group with an enrichment (P<0.05, Table II ).
Construction of lncRNA:mRNA association networks.
Using the statistically significant bij-association scores, we constructed association networks including the differently expressed lncRNAs and target genes (Fig. 4) . The resulting lncRNA:mRNA association network had 175 nodes and 104 connections between the 91 lncRNAs and the 84 mRNAs. This network indicated that TBXA2R were predicted to be targets of 31 lncRNAs, GRIN1 were targeted by seven of the lncRNAs, TNFRSF14 were targeted by six of the lncRNAs, and five mRNAs (ACOX1, COMP, CSF3, IGF1 and RASGRP4) were targeted by four of the lncRNAs. Most of the targets mentioned here have been reported to be linked to cancer. For example, high levels of TBXA2R has been previously reported in various tumors including prostate, glioma, melanoma, adenocarcinoma and squamous cell carcinoma of the lung (15) . Similarly, TBXA2R expression has been shown to influence endothelial cell migration and angiogenesis (16) . Furthermore, TBXA2R levels are associated with disease-free survival, indicating that the receptor is a prognostic factor in clinical breast cancer (17) . ANXA2 up-regulation was reported to be associated with human hepatocellular carcinoma, pancreatic adenocarcinoma, high-grade glioma, gastric carcinoma, acute promyelocytic leukemia and primary colorectal cancer (18) .
ASLNC22381 and ASLNC20819 might be the key regulators of glioma pathway in GBM.
The lncRNA-mRNA interaction networks related to the pathway we predicted previously are established in Fig. 4 . As shown in Fig. 5 , the up-regulated lncRNAs ASLNC22381 and ASLNC20819 showed the important position in the glioma pathway. The ASLNC22381 and ASLNC20819 is predicted to target growth factor-related IGF-1 genes, which might play an important role in the recurrence and malignant progression of glioma (19) .
Discussion
GBM is the most common and aggressive type of primary brain tumor in humans, involving glial cells and accounting for 52% of all parenchymal brain tumor cases and 20% of all intracranial tumors (20) . GBM is located preferentially in the cerebral hemispheres. In the past two decades, the molecular mechanisms to treat GBM have extensively been studied. However, the pathogenesis of this disease is still vague, and the gene regulation involved in this disease has been unclear until now. Increasing evidence has confirmed lncRNAs to be one of the most important factors controlling gene expression (21) . Therefore, we evaluated the lncRNA expression profile in the tissue of GBM patient to reveal the potential role of lncRNAs in Recent studies demonstrate that lncRNAs can guide changes in gene expression either in cis (on neighboring genes) or in trans (distantly located genes) manner that is not easily predicted based on lncRNA sequence (22, 23) . In principle, lncRNAs can guide chromatin change in cis in a cotranscriptional manner (tethered by RNA polymerase) or as a complementary target for small regulatory RNAs; guidance in trans can occur by lncRNA binding to target DNA as an RNA:DNA heteroduplex, as RNA:DNA:DNA triplex, or RNA recognition of complex surface of specific chromatin features (9).
The role of lncRNAs in disease processes creates an urgency to understand the mechanisms by which these RNAs seek their targets. The earliest lncRNAs suggested a simplistic model where the RNA remains tethered to the site of origin to regulate transcriptional changes in cis. Perhaps the most intensely studied and best understood cis mechanism of regulation by lncRNAs is the mammalian X inactivation center (Xic), a genetic locus that specifies a number of lncRNAs, including Xist (22) . Target genes of cis mechanism of regulation by lncRNAs were predicted via genome browser and annotation tool.
In contrast to the group of cis-regulatory lncRNAs, there are a couple of examples of lncRNAs that exert their transcriptional effects across chromosomes in trans. Here we have introduced the program RNAplex algorithms which reduces the time needed to localize putative hybridization sites, mainly by neglecting intramolecular interactions and by using a slighlty simplified energy model (12) . Combined with, e.g. RNAup we can find high-confidence targets, with only a slight loss of sensitivity. Finally apart from the speed improvement, RNAplex in contrast to similar programs, can recover short, highly stable interactions between two RNAs, by introducing a per nucleotide penalty. As a consequence, RNAplex is well suited for localizing putative lncRNA interactions partners in large amount of genomic data.
To improve the accuracy of target prediction, we further combined differentially expressed mRNA with target prediction of differentially expressed lncRNAs. In order to gain insight into the function of targets of lncRNAs, GO term and KEGG pathway annotation were applied to their target gene pool. KEGG annotation showed a significant change with the PPAR signaling pathway in the GBM group compared with the normal brain group (Fig. 3, and Tables I and II) . Further investigation of the lncRNA-gene network showed that the ASLNC22381 and ASLNC20819 was predicted to target growth factor-related IGF-1 genes of the glioma pathway, which might play an important role in the recurrence and malignant progression of glioma (Figs. 4 and 5) (19) .
In conclusion, our study revealed for the first time the lncRNAs that are differentially expressed in GBM when compared with the normal brain tissue. Their regulation roles in the PPAR signaling pathways may be involved in the pathogenesis of the GBM. Moreover, ASLNC22381 and ASLNC20819 may have great importance in the glioma pathway via their target IGF-1 and contribute to recurrence and malignant progression of glioma, but confirmation and elucidation of this mechanism requires further study. Present results also point to several exciting directions for future research. Each possible lncRNA-mRNA pair we identified is a strong candidate for a major study to definitively confirm the presence of specific lncRNA-mRNA interactions, thus creating a more detailed picture of the pathogenesis of GBM. 
